Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women

被引:768
作者
Warren, JW
Abrutyn, E
Hebel, JR
Johnson, JR
Schaeffer, AJ
Stamm, WE
机构
[1] Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA
[2] Univ Maryland, Dept Epidemiol, Baltimore, MD 21201 USA
[3] Med Coll Penn & Hahnemann Univ, Sch Med, Dept Med, Philadelphia, PA 19102 USA
[4] Dept Vet Affairs Med Ctr, Div Infect Dis, Minneapolis, MN USA
[5] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA
[6] Univ Washington, Med Ctr, Div Allergy & Infect Dis, Seattle, WA 98195 USA
关键词
D O I
10.1086/520427
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
This is part of the series of practice guidelines commissioned by the Infectious Diseases Society of America (IDSA) through its Practice Guidelines Committee. The purpose of this guideline is to provide assistance to clinicians in the diagnosis and treatment of two specific types of urinary tract infections (UTIs): uncomplicated, acute, symptomatic bacterial cystitis and acute pyelonephritis in women. The guideline does not contain recommendations for asymptomatic bacteriuria, complicated UTIs, Foley catheter-associated infections, UTIs in men or children, or prostatitis. The targeted providers are internists and family practitioners. The targeted groups are immunocompetent women. Criteria are specified for determining whether the inpatient or outpatient setting is appropriate for treatment. Differences from other guidelines written on this topic include use of laboratory criteria for diagnosis and approach to antimicrobial therapy. Panel members represented experts in adult infectious diseases and urology. The guidelines are evidence-based. A standard ranking system is used for the strength of the recommendation and the quality of the evidence cited in the literature reviewed. The document has been subjected to external review by peer reviewers as well as by the Practice Guidelines Committee and was approved by the IDSA Council, the sponsor and supporter of the guideline. The American Urologic Association and the European Society of Clinical Microbiology and Infectious Diseases have endorsed it. An executive summary and tables highlight the major recommendations. Performance measures are described to aid in monitoring compliance with the guideline. The guideline will be listed on the IDSA home page at http://www.idsociety.org It will be evaluated for updating in 2 years.
引用
收藏
页码:745 / 758
页数:14
相关论文
共 81 条
[1]
[Anonymous], 1990, NIH PUBL
[2]
URINARY-TRACT INFECTIONS WITH LOW AND HIGH COLONY COUNTS IN YOUNG-WOMEN - SPONTANEOUS REMISSION AND SINGLE-DOSE VS MULTIPLE-DAY TREATMENT [J].
ARAVBOGER, R ;
LEIBOVICI, L ;
DANON, YL .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (03) :300-304
[3]
RUFLOXACIN ONCE-DAILY VERSUS CIPROFLOXACIN TWICE-DAILY IN THE TREATMENT OF PATIENTS WITH ACUTE UNCOMPLICATED PYELONEPHRITIS [J].
BACH, D ;
VANDENBERGSEGERS, A ;
HUBNER, A ;
VANBREUKELEN, G ;
CESANA, M ;
PLETAN, Y .
JOURNAL OF UROLOGY, 1995, 154 (01) :19-24
[4]
Baerheim A, 1987, Scand J Prim Health Care, V5, P87, DOI 10.3109/02813438709013982
[5]
BAILEY RR, 1985, NEW ZEAL MED J, V98, P387
[6]
TREATMENT OF ACUTE URINARY-TRACT INFECTION IN WOMEN [J].
BAILEY, RR ;
PEDDIE, BA .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) :430-430
[7]
DURATION OF ANTIMICROBIAL TREATMENT AND THE USE OF DRUG-COMBINATIONS FOR THE TREATMENT OF UNCOMPLICATED ACUTE PYELONEPHRITIS [J].
BAILEY, RR .
INFECTION, 1994, 22 :S50-S52
[8]
BAILEY RR, 1983, SINGLE DOSE THERAPY, P1
[9]
TREATMENT OF PYELONEPHRITIS IN ADULTS [J].
BERGERON, MG .
MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (03) :619-649
[10]
OFLOXACIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE IN ACUTE CYSTITIS [J].
BLOCK, JM ;
WALSTAD, RA ;
BJERTNAES, A ;
HAFSTAD, PE ;
HOLTE, M ;
OTTEMO, I ;
SVARVA, PL ;
ROLSTAD, T ;
PETERSON, LE .
DRUGS, 1987, 34 :100-106